Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Benchmarking on PAP and Paracetamol Production in China

Published by: CCM International Limited

Published: Nov. 21, 2008 - 116 Pages


Table of Contents


Executive summary

Introduction and methodologies

I Review of PAP & paracetamol industry

I1 Brief introduction to paracetamol industry in China

I2 Brief introduction to PAP industry in China

II Brief introduction to various technologies of PAP and paracetamol

II1 Introduction to processes for PAP production

II1.1 Industralized technologies of PAP in China

Iron reduction of pnitrophenol

Catalytic hydrogenation of pnitrophenol

Catalytic hydrogenation of nitrobenzene

II1.2 Technologies under research

Electrolytic reduction of nitrobenzene

Other findings

II1.3 Comparison among the above four technologies

II2 Introduction to processes for paracetamol production

II2.1 Onestep method

II2.2 Twostep method

III Detailed introduction to most popular methods of PAP and paracetamol

III1 Technology for PAP

III1.1 Description of production process and theoretical model of raw materials by iron reduction technology

III1.2 Description of production process and theoretical model of raw materials by nitrobenzene catalytic hydrogenation technology

III2 Technology for paracetamol

III2.1 Brief description of production process

III2.2 Flow chart of paracetamol production

III2.3 Theoretical model of raw materials

IV Estimation on cost and profit of PAP and paracetamol

IV1 In PAP enterprises

IV1.1 Jiangsu Zhongming (adopting PNCB technology)

Basic situation in Jiangsu Zhongming

Financial analysis of Jiangsu Zhongming in 2007

Estimation on raw material cost

Estimation on manufacturing cost

Estimation on management cost

Estimation on tatal production cost

Estimation on profit

IV1.2 Liaoning Tianbao (adopting PNCB technology)

Basic situation in Liaoning Tianbao

Financial analysis of Liaoning Tianbao in 2007

Estimation on raw material cost

Estimation on manufacturing cost


Estimation on management cost

Estimation on profit

IV1.3 Liaoning Jinhuaiadopting NB technologyj

Basic situation in Huludao Jinhu

Estimation on raw material cost

Estimation on manufacturing cost

Estimation on management cost

Estimation on profit

IV1.4 Comparison among above three manufacturers

IV2 In paracetamol enterprises

IV2.1 Hebei Jiheng

Basic situation in Hebei Jiheng

Actual flowchart in Hebei Jiheng

Financial analysis of Hebei Jiheng in 2007

Estimation on raw material cost

Estimation on manufacturing cost

Estimation on management cost

Estimation on total production cost

Estimation on profit

IV2.2 Lufan Pharm

Basic situation in Lufan Pharm

Financial analysis of Lufan Pharm in 2007

Estimation on raw material cost

Estimation on manufacturing cost

Estimation on management cost

Estimation on total production cost

Estimation on profit

IV2.3 Comparison between Hebei Jiheng and Lufan Pharm in profit

V Forecast on PAP & paracetamol industry in China

V1 Forecast on market

V2 Forecast on technology

V3 Competitive power of Chinese paracetamol

VI Site Visit Reports



LIST OF TABLES

Table 1 Production situation of Chinese PAP producers, Nov2008

Table 2 RMB/USD exchange rates, 19942008

Table I11 Output of NSAIDs in China in 2007

Table I12 Output, export, import and domestic consumption of paracetamol in China, 1998~2007

Table I13 Average export price of Chinese paracetamol in 2007 and JanAug. 2008

Table I21 Export of Chinese PAP, 2000~2007

Table II11 Major technologies of PAP production in China, 2008

Table II12 Technologies adopted by overseas PAP producers

Table II13 Production situation of Chinese PAP producers, Oct2008

Table II1.21 Main patents on catalytic hydrogenation of nitrobenzene, 20042008

Table II1.3 1 Comparison among different technologies, Oct2008

Table II2.31 Key researchers on paracetamol in China

Table III1.11 Theoretical consumption of raw material of PAP in China, Oct2008

Table III1.21 Theoretical consumption of raw material of PAP in China, Oct2008

Table III2.31 Theoretical estimation on raw material costs of paracetamol

Table IV1.11 Main equipment in Jiangsu Zhongming

Table IV1.12 General situation of Jiangsu Zhongming, Oct2008

Table IV1.13 Balance sheet of Jiangsu Zhongming in 2007

Table IV1.14 Income statement of Jiangsu Zhongming in 2007

Table IV1.15 Cash flow statement of Jiangsu Zhongming in 2007

Table IV1.16 Financial analysis of Jiangsu Zhongming in 2007

Table IV1.17 Raw material costs of PAP in Jiangsu Zhongming in Oct2008

Table IV1.18 Estimation on manufacturing costs of PAP production in Jiangsu Zhongming, Oct2008

Table IV1.19 Estimation on management cost of Jiangsu Zhongming in Oct2008

Table IV1.110 Estimation on total production costs in Jiangsu Zhongming, Oct2008

Table IV1.111 Tax ratio in China

Table IV1.112 Estimation on profit of Jiangsu Zhongming, Oct2008

Table IV1.21 List of main sets of equipment in Liaoning Tianbao, Oct2008

Table IV1.22 General situation of Liaoning Tianbao

Table IV1.23 Balance sheet of Liaoning Tianbao in 2007

Table IV1.24 Income statement of Liaoning Tianbao in 2007

Table IV1.25 Cash flow statement of Liaoning Tianbao in 2007

Table IV1.26 Financial analysis of Liaoning Tianbao in 2007

Table IV1.27 Raw material costs of PAP in Liaoning Tianbao in Oct2008

Table IV1.28 Estimation on manufacturing costs of PAP production in Liaoning Tianbao, Oct2008

Table IV1.29 Estimation on management cost of Jiangsu Zhongming, Oct2008

Table IV1.210 Estimation on profit of Liaoning Tianbao, Oct2008

Table IV1.31 Estimation on raw material cost of PAP in Liaoning Jinhua, Oct2008

Table IV1.32 Estimation on manufacturing costs of PAP production in Liaoning Jinhua, Oct2008

Table IV1.33 Estimation on management cost of Liaoning Jinhua, Oct2008

Table IV1.34 Estimation on profit of Liaoning Jinhua

Table IV1.41 Comparison of cost between Jiangsu Zhongming and Liaoning Tianbao, Oct2008

Table IV1.42 Comparison of income and profit between Jiangsu Zhongming and Liaoning Tianbao, Oct2008

Table IV1.43 Comparison of cost and profit between Jiangsu Zhongming, Liaoning Tianbao and Liaoning Jinhua, Oct2008

Table IV2.11 Balance sheet of Hebei Jiheng in 2007

Table IV2.12 Income statement of Hebei Jiheng in 2007

Table IV2.13 Cash flow statement of Hebei Jiheng in 2007

Table IV2.14 Financial analysis of Hebei Jiheng in 2007

Table IV2.15 Estimation on raw material costs of paracetamol in Hebei Jiheng

Table IV2.16 Manufacturing costs of paracetamol production in Hebei Jiheng

Table IV2.17 Estimation on management cost of Hebei Jiheng

Table IV2.18 Estimation of total production cost in Hebei Jiheng

Table IV2.19 The profit estimation of paracetamol in Hebei Jiheng

Table IV2.21 Balance sheet of Lufan Pharm in 2007

Table IV2.22 Income statement of Lufan Pharm in 2007

Table IV2.23 Cash flow statement of Lufan Pharm in 2007

Table IV2.24 Financial analysis of Lufan Pharm in 2007

Table IV2.25 Estimation on raw material costs of paracetamol in Lufan Pharm

Table IV2.26 Manufacturing costs of paracetamol production in Lufan Pharm

Table IV2.27 Estimation on management cost of Lufan Pharm

Table IV2.28 Estimation of total production cost in Lufan Pharm

Table IV2.29 The profit estimation of paracetamol in Lufan Pharm

Table IV2.31 Comparison between Hebei Jiheng and Lufan Pharm in Oct 2008

Table V21 Estimation on future technology structure of PAP in China, tonnes, 20082015

Table V31 SWOT analysis of the top five paracetamol manufacturers in China

Table VI11 List of main equipment of PAP production in Jiangsu Zhongming

Table VI12 PAP specification in Jiangsu Zhongming

Table VI21 List of main equipments in Liaoning Tianbao

Table VI22 PAP specification in Liaoning Tianbao

Table VI31 Equipments affiliated to 3,000 t/a PAP production line in Liaoning Tiancheng


LIST OF FIGURES

Figure1 Forecast on technology structure of PAP in China, 20082015

Figure I11 Market share of main NSAIDs in China in 2007

Figure I12 Export situation to different destinations of Chinese paracetamol, 2003~2007

Figure 113 Average export price of Chinese paracetamol, 1999~2007

Figure I21 Output of PAP in China, 1998~2007

Figure I22 Export volume and price of PAP produced by different process in China, 2000~2007

Figure I23 Consumption structure of PAP in China, 2007

Figure V21 Forecast on technology structure of PAP in China, 20082015, by output volume

Figure V22 Forecast on technology structure of PAP in China, 20082015, by output share

Abstract

The consumption of paracetamol, which takes the most important position among NSAIDs, has kept growing worldwide, which promotes the production of PAP, the key raw material of paracetamol.

As one of main paracetamol manufacturers in the world, China's paracetamol export has constituted 30%-40% of the total paracetamol consumed in the world. On the other hand, process of PAP and paracetamol in China is improving, largely attributable to the governmental environmental protection policy.

However, China’s PAP manufacturers’ profit has been further squeezed by the growing investment in environmental protection and the global economic depression in 2008.

To further penetrate into the industry, especially the production process, CCM has produced a report of Benchmarking on PAP and Paracetamol Production in China, which will provide you with the answers to the following questions:
  • What are the developing status and trends of the production processes of PAP and paracetamol in China?
  • What are the production costs of these process by theoretical model?
  • What are the actual production cost and total profit of benchmark enterprises of PAP and paracetamol in this report in China?
  • How are the total profit comparison between benchmark enterprises of PAP and paracetamol?
  • What are the financial analysis of benchmark enterprises in 2007?
  • What are the prospective technologies of PAP production in China till 2015?


Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report

Price and Delivery Options

See related reports or call the number above for help from a research specialist.


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2009